Related references
Note: Only part of the references are listed.Connexins in cancer: bridging the gap to the clinic
Trond Aasen et al.
ONCOGENE (2019)
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
Christina L. Grek et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Therapeutic strategies targeting connexins
Dale W. Laird et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels
Yeri Kim et al.
NEUROTHERAPEUTICS (2017)
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
Susan F. Murphy et al.
CANCER RESEARCH (2016)
Astrocytes promote glioma invasion via the gap junction protein connexin43
W. C. Sin et al.
ONCOGENE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Patient-derived glioblastoma stem cells respond differentially to targeted therapies
Pratik Kanabur et al.
ONCOTARGET (2016)
Gap junctions and cancer: communicating for 50 years
Trond Aasen et al.
NATURE REVIEWS CANCER (2016)
Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Sang-Soo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Brain tumour cells interconnect to a functional and resistant network
Matthias Osswald et al.
NATURE (2015)
Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy
G. M. Yusubalieva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP)
Julie Bolcaen et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
J. L. Munoz et al.
CELL DEATH & DISEASE (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway
Paul R. Gielen et al.
NEUROPHARMACOLOGY (2013)
Opposing roles of connexin43 in glioma progression
Wun-Chey Sin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies
Vladimir P. Baklaushev et al.
DRUG DELIVERY (2011)
Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels
Qingtang Lin et al.
NEOPLASIA (2010)
Implications and challenges of connexin connections to cancer
Christian C. Naus et al.
NATURE REVIEWS CANCER (2010)
Connexin-related signaling in cell death: to live or let die?
E. Decrock et al.
CELL DEATH AND DIFFERENTIATION (2009)
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
Rolf F. Barth et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study
Anne W. Hauge et al.
LANCET NEUROLOGY (2009)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
